SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
TITAN PHARMACEUTICAL (TTP)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
362 31 0 TTP
Emcee:  matt wolf Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
62 Thanks Guys, Hi Rick & Miljenko. I was curious about this. Interesting. BRAVEHEART-5/18/1999
61 <<Anybody here believe this?>> No, not a single word! They done sMiljenko Zuanic-5/17/1999
60 <i>In addition, Dr. Bucalo stated that, ''We are also planning toscaram(o)uche-5/17/1999
59 *Brother* results (also reason that I am optimistic about iloperidone): SOURCEMiljenko Zuanic-5/14/1999
58 Do not know. I think that it is to early for any data from PII trials (CeaVac,Miljenko Zuanic-5/12/1999
57 Miljenko--I gather that TTP will be presenting some data on their cancer trialsJOEBT1-5/12/1999
56 Hark, I don't own shares in TTP. I do somewhat follow them. In my opinionJames Silverman-5/11/1999
55 Long time no hear. Any special reason for Titan? Are you still following BRLharkenman-5/10/1999
54 Long time no hear. Any reason for titan? Are you still following BRL, DRMD? harkenman-5/10/1999
53 I think that they have a patent (incorporated in) for PIVONEX formulation. I wiMiljenko Zuanic-4/25/1999
52 OK, but I still think that may be the patent. I'll check further. Thanks!scaram(o)uche-4/25/1999
51 I guess not. PIVANEX is pivaloyl-oxy-methyl butyrate derivative, the some proMiljenko Zuanic-4/25/1999
50 Miljenko: Is this the piv patent? Not much published lately about butyrate. scaram(o)uche-4/25/1999
49 <i>Perhaps Nurse Cratched prefers injections</i> Have you <b&gBiomaven-4/24/1999
48 >> On another note, someone must have suggested they correct the spellingscaram(o)uche-4/24/1999
47 The ALKS/JNJ project is interesting. I agree its not really competition. Its James Silverman-4/23/1999
46 status of some competition, not really competition actually, but sort of.......scaram(o)uche-4/22/1999
45 just a little background regarding the abstract by Morriset et al.... Naunyn Sscaram(o)uche-4/20/1999
44 <i>Lilly's Zyprexa schizophrenia drug has stolen mscaram(o)uche-4/20/1999
43 from today's S-3..... <i>Our lead product, Iloperidone, is currentlyscaram(o)uche-4/7/1999
42 J Pharmacol Exp Ther 1999 Feb;288(2):590-6 Atypical neuroleptics enhance histscaram(o)uche-2/13/1999
41 I still find it helpful, looking at the market cap for CLPA, to think of piv inscaram(o)uche-1/26/1999
40 Surgery 1998 Aug;124(2):248-53 Butyrate inhibits colon carcinoma cell growth scaram(o)uche-1/20/1999
39 Thanks, P.B. Int J Cancer 1998 Dec 9;78(6):735-9 Interleukin-2/sodium butyrascaram(o)uche-1/20/1999
38 Thanks Pseudo, haven't heard from you in a while on VICL or ISIP. Scott Scott H. Davis-1/20/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News